Contemporary management of neuropathic pain for the primary care physician.

Chen H, Lamer TJ, Rho RH, Marshall KA, Sitzman BT, Ghazi SM, Brewer RP

Mayo Clin Proc, (12):1533-1545 2004

MED: 15595338

Title not supplied

Ashcroft

2000

Medicinal chemistry of neuronal voltage-gated sodium channel blockers.

Anger T, Madge DJ, Mulla M, Riddall D

J Med Chem, (2):115-137 2001

MED: 11170622

The role of sodium channels in chronic inflammatory and neuropathic pain.

Amir R, Argoff CE, Bennett GJ, Cummins TR, Durieux ME, Gerner P, Gold MS, Porreca F, Strichartz GR

J Pain, (5 Suppl 3):S1-29 2006

MED: 16632328

The response of neuropathic pain and pain in complex regional pain syndrome I to carbamazepine and sustained-release morphine in patients pretreated with spinal cord stimulation: a double-blinded randomized study.

Harke H, Gretenkort P, Ladleif HU, Rahman S, Harke O

Anesth Analg, (2):488-495 2001

MED: 11159256

Systemic local-anaesthetic-type drugs in chronic pain: a systematic review.

Kalso E, Tramer MR, McQuay HJ, Moore RA

Eur J Pain, (1):3-14 1998

MED: 10700296

Systemic lidocaine for neuropathic pain relief.

Mao J, Chen LL

Pain, (1):7-17 2000

MED: 10863041

Anti-allodynic effect of NW-1029, a novel Na(+) channel blocker, in experimental animal models of inflammatory and neuropathic pain.

Veneroni O, Maj R, Calabresi M, Faravelli L, Fariello RG, Salvati P

Pain, (1-2):17-25 2003

MED: 12620593

Gain-of-function mutation in Nav1.7 in familial erythromelalgia induces bursting of sensory neurons.

Dib-Hajj SD, Rush AM, Cummins TR, Hisama FM, Novella S, Tyrrell L, Marshall L, Waxman SG

Brain, (Pt 8):1847-1854 2005

MED: 15958509

SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes.

Fertleman CR, Baker MD, Parker KA, Moffatt S, Elmslie FV, Abrahamsen B, Ostman J, Klugbauer N, Wood JN, Gardiner RM, Rees M

Neuron, (5):767-774 2006

MED: 17145499